Glucotrack, Inc. 8-K

What Happened
Glucotrack, Inc. announced its financial and operating results for the quarter ended March 31, 2026 via a press release issued and furnished on May 14, 2026. The company filed an 8-K (Item 2.02) to disclose these quarterly results and included the press release as an exhibit.

Key Details

• Filing date: May 14, 2026 (Form 8-K, Item 2.02).
• Period covered: quarter ended March 31, 2026.
• Press release furnished as Exhibit 99.1 to the 8-K.
• Interactive XBRL cover page included (Exhibit 104).

Why It Matters
This 8-K signals that Glucotrack has publicly released its latest quarterly earnings and operating metrics; investors should review the Exhibit 99.1 press release (and any accompanying XBRL disclosures) to see revenue, earnings, cash flow, and operational updates that could affect the stock. The filing itself is a formal disclosure of those results to the market.